• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

NPJ Vaccines . Impact of host genetic polymorphisms on response to inactivated influenza vaccine in children

tetano

Editor, Senior Moderator
NPJ Vaccines


. 2023 Feb 20;8(1):21.
doi: 10.1038/s41541-023-00621-1.
Impact of host genetic polymorphisms on response to inactivated influenza vaccine in children


Tim K Tsang[SUP] 1 2 [/SUP], Can Wang[SUP] 3 [/SUP], Nicole N Y Tsang[SUP] 3 [/SUP], Vicky J Fang[SUP] 3 [/SUP], Ranawaka A P M Perera[SUP] 3 [/SUP], J S Malik Peiris[SUP] 3 4 [/SUP], Gabriel M Leung[SUP] 3 5 [/SUP], Benjamin J Cowling[SUP] 3 5 [/SUP], Dennis K M Ip[SUP] 6 [/SUP]



Affiliations
Free PMC article

Abstract

In randomized controlled trials of influenza vaccination, 550 children received trivalent-inactivated influenza vaccine, permitting us to explore relationship between vaccine response and host single nucleotide polymorphisms (SNPs) in 23 candidate genes with adjustment of multiple testing. For host SNPs in TLR7-1817G/T (rs5741880), genotype GT was associated with lower odds (OR: 0.22, 95% CI: 0.09, 0.53) of have post-vaccination hemagglutination-inhibiting (HAI) titers ≥40, compared with genotype GG and TT combined under the over-dominant model. For host SNPs in TLR8-129G/C (rs3764879), genotype GT was associated with lower odds (OR: 0.47; 95% CI: 0.28, 0.80) of have post vaccination HAI titers ≥40 compared with genotype GG and AA combined under the over-dominant model. Our results could contribute to the development of better vaccines that may offer improved protection to all recipients.
 
Back
Top Bottom